Trimebutine
Trimebutine is a medication primarily used for the treatment of irritable bowel syndrome (IBS) and other gastrointestinal disorders. It acts as a spasmolytic agent, which means it helps to relieve muscle spasms in the intestines.
Mechanism of Action[edit]
Trimebutine works by modulating the activity of the gastrointestinal tract. It acts on the mu, delta, and kappa opioid receptors in the gut, which helps to normalize the motility of the intestines. This action can help to alleviate symptoms such as abdominal pain, bloating, and diarrhea or constipation associated with IBS.
Uses[edit]
Trimebutine is used in the management of various gastrointestinal conditions, including:
- Irritable bowel syndrome (IBS)
- Functional dyspepsia
- Gastroesophageal reflux disease (GERD)
- Postoperative ileus
Side Effects[edit]
Common side effects of trimebutine may include:
Serious side effects are rare but can include allergic reactions such as rash, itching, and swelling.
Dosage and Administration[edit]
Trimebutine is typically administered orally in the form of tablets or suspension. The dosage and duration of treatment depend on the specific condition being treated and the patient's response to the medication.
Contraindications[edit]
Trimebutine should not be used in individuals with a known hypersensitivity to the drug or any of its components. It should be used with caution in patients with severe hepatic or renal impairment.
Pharmacokinetics[edit]
Trimebutine is rapidly absorbed from the gastrointestinal tract and undergoes extensive first-pass metabolism in the liver. It is primarily excreted in the urine.
History[edit]
Trimebutine was first developed in the 1960s and has been used in various countries for the treatment of gastrointestinal disorders. It is available under several brand names, including Debridat and Mebeverine.
See Also[edit]
References[edit]
External Links[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
